DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20182447

Quality of life of women with polycystic ovarian syndrome

Prabha Dey

Abstract


Background: Polycystic ovary syndrome (PCOS), also known as hyper androgenic anovolation (HA or Stein-Leventhal syndrome) is a well-recognised and common condition that causes considerable morbidity. The objective of the present study was to find out the quality of life of women with polycystic ovarian syndrome.

Methods: Patients with PCOD diagnosed clinically at out patients department were selected for the study. SF 36 was applied to find out the Quality of life of women with polycystic ovarian syndrome.

Results: A total of 84 patients were participated and 75% of the sample were student, 56.7% were graduate and 86.7% were non-vegetarian. The mean height of the sample was 155±4.81 centimeters. The mean weight of sample was 59.35±6.63 kgs and BMI mean was 24.70±3.47. Among 35% the duration of diagnosis was less than one year and for 65% it was more than one year. Means of the all sub set scores, across shorter and longer duration of being diagnosed as PCOD were significantly same on t test.

Conclusions: Measured by SF 36, women with poly cystic ovarian disease/symptoms are suffering from significantly lowered quality of life, but independent of their duration of illness.


Keywords


Polycystic ovarian syndrome, PCOD, Quality of life

Full Text:

PDF

References


Balen A, Homberg R, Frank S. Defining polycystic ovary syndrome. Br Med J. 2009;338:a2968.

Sonino N, Fava GA, Mani E. Quality of life of hirsute women. Postgrad Med J. 1993, 69(809):186-9.

Paulson JD, Haarmann BS, Salerno RL, Asmar P. An investigation of the relationship between emotional maladjustment and infertility. Fertil Steril. 1988, 49(2):258-62.

Downey J, Yingling S, McKinney M, Husami N, Jewelewicz R, Maidman J. Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil Steril. 1989;52(3):425-32.

Dokras A. Cardiovascular disease risk in women with PCOS. Steroids. 2013;78(8):773-6.

Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442-51.

Naughton MJ, McBee WL. Health‐related quality of life after hysterectomy. Clin Obstet Gynecol. 1997; 40(4): 947-7.

Colwell H, Mathias SD, Pasta DJ, Henning JM and Steege JF. A health‐related quality of life instrument for symptomatic patients with endometriosis: a validation study. Am J Obstet Gynecol. 1998;179(12):47-55.

Streiner DL, Norman G. Health Measurement Scales: A Practical Guide to their Development and Use. 2nd ed, Oxford University Press, Oxford, UK;2000.

Benetti-Pinto CL, Ferreira SR, Antunes A Jr, Yela DA. The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2015;291(2):451-5.

Kozak AT, Daviglus ML, Chan C, Kiefe C, Jacobs D, Liu K. Relationship of body mass index in young adulthood and health-related quality of life two decades later: the Coronary Artery Risk Development in Young Adults Study. Int J Obestet. 2011;35(1):134-41.

Grivetti L. Psychology and cultural aspects of energy. Nutr Rev. 2001;59(1):5-s12.

Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol. 2005;152(5):986-92.

Coffey S, Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol Endocrinol. 2003;17(5):379-86.

Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80-6.

Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clil Endocrinol. 2007;66(3):373-79.